skip to content

Positions, policies & downloads

Sustainability Download Centre

download centre
2026/03Animal Research at Roche PositionPDF
2026/01Finance Report 2025BrochurePDF
2026/01Annual Report 2025BrochurePDF
2026/01Roche Climate-Related Claims Disclosure StatementPositionPDF
2026/01Policy on Safety, Security, Health and Environmental Protection PolicyPDF
2025/07Half-Year Report 2025BrochurePDF
2025/03Employment Policy (English) PolicyPDF
2025/02Supporting BiodiversityFact SheetPDF
2025/02Greenhouse gas emissionsPositionPDF
2025/01Roche Global Policy on Continued Access to Investigational InterventionsPolicyPDF
2025/01Finance Report 2024BrochurePDF
2025/01Annual Report 2024BrochurePDF
2024/08Roche’s Approach to Tax – General Description and PrinciplesPrinciplesPDF
2024/08Roche Position on TRIPS and the Doha Declaration Position PDF
2024/07PricingPositionPDF
2024/07Half-Year Report 2024BrochurePDF
2024/04Roche Position on Race, Ethnicity, and Genetic Ancestry Application and Use in Clinical Trials and Product DevelopmentPositionPDF
2024/02Six bold actions for regulatory reform (EU) 2024PositionPDF
2024/02Finance Report 2023BrochurePDF
2024/02Annual Report 2023BrochurePDF
2023/11 Roche AI Ethics PrinciplesPrinciplesPDF
2013/11 Risk Management PolicyPDF
2023/11Pre-Approval Access to Investigational Medicinal ProductsPositionPDF
2023/09Roche Policy on sharing of clinical study information PolicyPDF
2023/07Supplier Code of Conduct (French)GuidelinesPDF
2023/07Supplier Code of Conduct (Spanish)GuidelinesPDF
2023/07Roche Group Code of Conduct - Addendum for France (French)PolicyPDF
2023/07Half-Year Report 2023BrochurePDF
2023/07Similar Biotherapeutic Products - Biosimilars PositionPDF
2023/03Roche Data Ethics PrinciplesPrinciplesPDF
2023/02Group Insider PolicyPolicyPDF
2023/02Human Stem CellsPositionPDF
2023/02Position on Human Specimen Resources (Biobanks)PositionPDF
2023/02Finance Report 2022BrochurePDF
2023/02Annual Report 2022BrochurePDF
2023/01Supplier Code of Conduct (German)GuidelinesPDF
2023/01Supplier Code of Conduct (English) GuidelinesPDF
2022/11NanotechnologyPositionPDF
2022/11Six bold actions for regulatory reform (EU)Position PDF
2022/11 Roche’s Position on Access to & Use of Real World Data PositionPDF
2022/10Roche FAQ Clinical ResearchFAQsPDF
2022/07 Half-Year Report 2022 BrochurePDF
2022/07 Roche position on incentivising the development and appropriate use of new antibiotics PolicyPDF
2022/06 EFPIA Disclosure Code Self-Certification Scheme Position PDF
2022/05 Responsible Sharing of Scientifically Credible Information on the portal Position PDF
2022/02 Finance Report 2021 Brochure PDF
2022/02 Annual Report 2021 Brochure PDF
2021/11 Roche Group Code of Conduct - Addendum for France (English) PolicyPDF
2021/09 Waste Management and Circular Economy PositionPDF
2021/07 Energy Conservation PositionPDF
2021/07 Prevention of Misuse of Biological Materials and Toxins for Biowarfare PositionPDF
2021/07 WaterPositionPDF
2021/07 Half-Year Report 2021 BrochurePDF
2021/06 EFPIA Disclosure Code Self-Certification Scheme PolicyPDF
2021/06 Roche Position on Enabling Access through Collaboration Position PDF
2021/05 Roche's Position on Partnering with Patient Communities PositionPDF
2021/02 Finance Report 2020 Brochure PDF
2021/02 Annual Report 2020 Brochure PDF
2021/02 Roche Position on Health Technology Assessment PositionPDF
2020/07 Half-Year Report 2020 Brochure PDF
2020/06 EFPIA Disclosure Code Self-Certification Scheme PolicyPDF
2020/04 BiodiversityPositionPDF
2020/04 Biotechnology - Safety Health and Environmental Aspects PositionPDF
2020/04 Clinical Research PositionPDF
2020/04 CounterfeitingPositionPDF
2020/04 Greenhouse gases / Climate Change PositionPDF
2020/04 Landfills / Contaminated Soil PositionPDF
2020/04 Personalised Healthcare PositionPDF
2020/04 Pharmaceuticals in the Environment PositionPDF
2020/04 R&D for Neglected Tropical Disease PositionPDF
2020/04 Pollution Prevention and Reduction PositionPDF
2020/04 Product Stewardship PositionPDF
2020/04 Safety, Security, Health and Environmental Protection (SHE) in the supply chain PositionPDF
2020/04 Human Rights PositionPDF
2020/04 Human Genetic and Genomic Research PositionPDF
2023/06 Roche Group Code of Conduct (Chinese) PolicyPDF
2023/06Roche Group Code of Conduct (German) PolicyPDF
2023/06 Roche Group Code of Conduct (Spanish) PolicyPDF
2023/06 Roche Group Code of Conduct (French) PolicyPDF
2023/06 Roche Group Code of Conduct - Addendum for France (French) PolicyPDF
2023/06 Roche Group Code of Conduct (Italian) PolicyPDF
2023/06 Roche Group Code of Conduct (Portuguese - Brasil) PolicyPDF
2023/06 Roche Group Code of Conduct (Japanese)PolicyPDF
2023/06 Roche Group Code of Conduct (Russian)PolicyPDF
2023/06 Roche Group Code of Conduct (Turkish) PolicyPDF
2023/06 Roche Group Code of Conduct (English) PolicyPDF
2020/01 Roche in Brief 2019 BrochurePDF
2020/01 Finance Report 2019 BrochurePDF
2020/01 Annual Report 2019 BrochurePDF
2019/07 Half-Year Report 2019 BrochurePDF
2019/07 EFPIA Disclosure Code Self-Certification Scheme PolicyPDF
2019/02 SHE Guidelines GuidelinesPDF
2019/01 Roche in Brief 2018 BrochurePDF
2019/01 Finance Report 2018 BrochurePDF
2019/01 Annual Report 2018 BrochurePDF
2019/01 ComplianceFact Sheet PDF
2019/01 Roche illness rate and occupational illnesses Fact Sheet PDF
2019/01 Supporting Biodiversity Fact Sheet PDF
2019/01 Waste Management Fact Sheet PDF
2019/01 Use of water Fact Sheet PDF
2019/01 Emissions to water Fact Sheet PDF
2019/01 Other emissions to air Fact Sheet PDF
2019/01 Greenhouse Gas Emissions Fact Sheet PDF
2019/01 Energy Consumption Fact Sheet PDF
2019/01 Eco-balance Fact Sheet PDF
2018/12 Roche Directive Collaborating with Patient Groups and Patients GuidelinesPDF
2018/10 Intellectual Property, Fueling Innovation & Advancing Healthcare PositionPDF
2018/10 Certificate on Roche's Sustainability Commitments, Initiatives and Performance Fact Sheet PDF
2018/07 Half-Year Report 2018 BrochurePDF
2018/06Group Business Continuity Management Policy PolicyPDF
2018/05 Working with Government Officials GuidelinesPDF
2018/05 Philanthropic Donations and Non-commercial Sponsorship PolicyPDF
2018/03 Organisationsreglement PolicyPDF
2018/03 BylawsPolicyPDF
2018/02 TransportFact Sheet PDF
2018/02 Roche in Brief 2017 BrochurePDF
2018/02 Finance Report 2017 BrochurePDF
2018/02 Annual Report 2017 BrochurePDF
2017/06 EFPIA Disclosure Code Self-Certification Scheme PolicyPDF
2017/05 Benefits - Switzerland BrochurePDF
2017/02 Full Year 2016 Presentation without appendix BrochurePDF
2017/02 Finance Report 2016 BrochurePDF
2016/06 Counterfeit Medicinal products FAQsPDF
2016/03 SHE Organization Chart Fact Sheet PDF
2016/03 Behaviour in Competition GuidelinesPDF
2016/03 Behaviour in Competition (German) GuidelinesPDF
2015/05 Roche Specimen Repositories FAQs PDF
2015/02 Directive K18 - Annex 2 (Lighting) BrochurePDF
2014/10 Directive K1 - Annex 5 (Mental Health Protection) PolicyPDF
2014/10 Directive K1 - Occupational Health PolicyPDF
2022/05 Behaviour in Business (English) GuidelinesPDF
2022/05 Behaviour in Business (German) GuidelinesPDF
2022/05 Behaviour in Business (French) GuidelinesPDF
2014/03 Minutes of the 96th Annual General Meeting of the Shareholders of ROCHE HOLDING LTD Fact Sheet PDF
2009/10 Memberships and International CR Recommendations Fact Sheet PDF

Discover more

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Our strategyAbout Roche

We focus on discovering new medicines, diagnostics and digital products that improve health outcomes, so that we all have more time with the people we love.

Improving access to healthcareAbout Roche

Our approach to increasing access to healthcare ensures our life-changing solutions reach people around the world.

Sustainability at RocheAbout Roche

At Roche, our ambition lies not only in transforming healthcare, but also in our contributions to environmental protection, supply chain sustainability, social commitment and philanthropy.

InvestorsInvestors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.

Investor downloadsInvestors

Access Roche's financial and non-financial presentations archived as downloads.